Thomas Partridge

692 total citations
13 papers, 449 citations indexed

About

Thomas Partridge is a scholar working on Immunology, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Thomas Partridge has authored 13 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 9 papers in Molecular Biology and 3 papers in Infectious Diseases. Recurrent topics in Thomas Partridge's work include vaccines and immunoinformatics approaches (8 papers), Immunotherapy and Immune Responses (6 papers) and HIV Research and Treatment (3 papers). Thomas Partridge is often cited by papers focused on vaccines and immunoinformatics approaches (8 papers), Immunotherapy and Immune Responses (6 papers) and HIV Research and Treatment (3 papers). Thomas Partridge collaborates with scholars based in United Kingdom, Australia and United States. Thomas Partridge's co-authors include Persephone Borrow, Anne Bridgeman, Jan Rehwinkel, Alice Mayer, Tao Dong, Tamara Davenne, Peng Yan, Jonathan Maelfait, Volkhard Kaever and Nicola Ternette and has published in prestigious journals such as Science, Journal of Virology and British Journal of Cancer.

In The Last Decade

Thomas Partridge

12 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Partridge United Kingdom 10 304 251 155 55 52 13 449
Kathryn Trandem United States 8 334 1.1× 116 0.5× 168 1.1× 49 0.9× 80 1.5× 11 571
Mahesh Chemudupati United States 8 202 0.7× 147 0.6× 115 0.7× 34 0.6× 103 2.0× 9 377
Mohamed Habbeddine France 10 267 0.9× 202 0.8× 117 0.8× 48 0.9× 65 1.3× 12 475
Tahnee L. Saunders United States 9 361 1.2× 282 1.1× 179 1.2× 42 0.8× 66 1.3× 13 555
Cristine J. Cooper United States 11 436 1.4× 102 0.4× 48 0.3× 84 1.5× 48 0.9× 14 584
Iwen F. Grigsby United States 10 195 0.6× 128 0.5× 66 0.4× 86 1.6× 50 1.0× 14 422
Samantha Reiss United States 7 360 1.2× 160 0.6× 194 1.3× 49 0.9× 98 1.9× 9 598
Shinwa Shibata Japan 11 167 0.5× 203 0.8× 51 0.3× 50 0.9× 37 0.7× 19 420
Zhenlu Chong United States 10 266 0.9× 183 0.7× 264 1.7× 36 0.7× 62 1.2× 14 534
Alex Olson United States 11 149 0.5× 93 0.4× 109 0.7× 36 0.7× 42 0.8× 21 351

Countries citing papers authored by Thomas Partridge

Since Specialization
Citations

This map shows the geographic impact of Thomas Partridge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Partridge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Partridge more than expected).

Fields of papers citing papers by Thomas Partridge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Partridge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Partridge. The network helps show where Thomas Partridge may publish in the future.

Co-authorship network of co-authors of Thomas Partridge

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Partridge. A scholar is included among the top collaborators of Thomas Partridge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Partridge. Thomas Partridge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Xu, Peng, Isaac Woodhouse, Gemma Hancock, et al.. (2023). Novel canonical and non-canonical viral antigens extend current targets for immunotherapy of HPV-driven cervical cancer. iScience. 26(3). 106101–106101. 8 indexed citations
2.
Paes, Wayne, Isaac Woodhouse, Thomas Partridge, et al.. (2022). HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes. Frontiers in Immunology. 13. 1067463–1067463. 15 indexed citations
3.
Xu, Peng, Isaac Woodhouse, Gemma Hancock, et al.. (2022). Novel Canonical and Non-Canonical Antigens That Extend Current Targets for Immunotherapy of HPV-Driven Cervical Cancer. SSRN Electronic Journal.
4.
Chikata, Takayuki, Wayne Paes, Nozomi Kuse, et al.. (2022). Impact of Micropolymorphism Outside the Peptide Binding Groove in the Clinically Relevant Allele HLA-C*14 on T Cell Responses in HIV-1 Infection. Journal of Virology. 96(10). e0043222–e0043222. 5 indexed citations
5.
Chauveau, Lise, Anne Bridgeman, Tiong Kit Tan, et al.. (2021). Inclusion of cGAMP within virus‐like particle vaccines enhances their immunogenicity. EMBO Reports. 22(8). e52447–e52447. 29 indexed citations
6.
Parker, Robert, Thomas Partridge, Rebeca Kawahara, et al.. (2021). Mapping the SARS-CoV-2 spike glycoprotein-derived peptidome presented by HLA class II on dendritic cells. Cell Reports. 35(8). 109179–109179. 48 indexed citations
7.
Paes, Wayne, et al.. (2020). Elucidation of the Signatures of Proteasome-Catalyzed Peptide Splicing. Frontiers in Immunology. 11. 563800–563800. 21 indexed citations
8.
Chikata, Takayuki, Wayne Paes, Tomohiro Akahoshi, et al.. (2019). Identification of Immunodominant HIV-1 Epitopes Presented by HLA-C*12:02, a Protective Allele, Using an Immunopeptidomics Approach. Journal of Virology. 93(17). 15 indexed citations
9.
Partridge, Thomas, Annalisa Nicastri, L.‐M. Yindom, et al.. (2018). Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows. Frontiers in Immunology. 9. 912–912. 33 indexed citations
10.
Ternette, Nicola, Hongbing Yang, Thomas Partridge, et al.. (2015). Defining the HLA class I‐associated viral antigen repertoire from HIV‐1‐infected human cells. European Journal of Immunology. 46(1). 60–69. 43 indexed citations
11.
Bridgeman, Anne, Jonathan Maelfait, Tamara Davenne, et al.. (2015). Viruses transfer the antiviral second messenger cGAMP between cells. Science. 349(6253). 1228–1232. 198 indexed citations
12.
Bagshawe, K D, et al.. (1987). A cytotoxic DNA precursor is taken up selectively by human cancer xenografts. British Journal of Cancer. 55(3). 299–302. 10 indexed citations
13.
Partridge, Thomas. (1982). The Role of the Major Histocompatibility Complex in Immunobiology. Journal of the Royal Society of Medicine. 75(8). 681–681. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026